This Practice Note explains what captive insurance is, who uses it and why, key structuring options (including protected cell companies), and the main legal, regulatory, capital and governance issues that arise in captive arrangements. It also summarises the UK government’s proposed captive insurer regime, including its scope, regulatory approach and expected implementation timeline.